QQQ   352.01 (+1.16%)
AAPL   180.09 (+1.60%)
MSFT   332.58 (+1.28%)
META   272.61 (+2.98%)
GOOGL   123.72 (+0.69%)
AMZN   122.77 (+1.82%)
TSLA   207.52 (+1.76%)
NVDA   397.70 (+5.12%)
NIO   7.54 (+0.13%)
BABA   82.99 (+4.32%)
AMD   119.47 (+1.07%)
T   15.82 (+0.51%)
F   12.11 (+0.92%)
MU   69.09 (+1.30%)
CGC   0.83 (+0.00%)
GE   104.66 (+3.08%)
DIS   88.59 (+0.72%)
AMC   4.55 (+0.89%)
PFE   38.04 (+0.03%)
PYPL   63.05 (+1.71%)
NFLX   403.13 (+2.00%)
QQQ   352.01 (+1.16%)
AAPL   180.09 (+1.60%)
MSFT   332.58 (+1.28%)
META   272.61 (+2.98%)
GOOGL   123.72 (+0.69%)
AMZN   122.77 (+1.82%)
TSLA   207.52 (+1.76%)
NVDA   397.70 (+5.12%)
NIO   7.54 (+0.13%)
BABA   82.99 (+4.32%)
AMD   119.47 (+1.07%)
T   15.82 (+0.51%)
F   12.11 (+0.92%)
MU   69.09 (+1.30%)
CGC   0.83 (+0.00%)
GE   104.66 (+3.08%)
DIS   88.59 (+0.72%)
AMC   4.55 (+0.89%)
PFE   38.04 (+0.03%)
PYPL   63.05 (+1.71%)
NFLX   403.13 (+2.00%)
QQQ   352.01 (+1.16%)
AAPL   180.09 (+1.60%)
MSFT   332.58 (+1.28%)
META   272.61 (+2.98%)
GOOGL   123.72 (+0.69%)
AMZN   122.77 (+1.82%)
TSLA   207.52 (+1.76%)
NVDA   397.70 (+5.12%)
NIO   7.54 (+0.13%)
BABA   82.99 (+4.32%)
AMD   119.47 (+1.07%)
T   15.82 (+0.51%)
F   12.11 (+0.92%)
MU   69.09 (+1.30%)
CGC   0.83 (+0.00%)
GE   104.66 (+3.08%)
DIS   88.59 (+0.72%)
AMC   4.55 (+0.89%)
PFE   38.04 (+0.03%)
PYPL   63.05 (+1.71%)
NFLX   403.13 (+2.00%)
QQQ   352.01 (+1.16%)
AAPL   180.09 (+1.60%)
MSFT   332.58 (+1.28%)
META   272.61 (+2.98%)
GOOGL   123.72 (+0.69%)
AMZN   122.77 (+1.82%)
TSLA   207.52 (+1.76%)
NVDA   397.70 (+5.12%)
NIO   7.54 (+0.13%)
BABA   82.99 (+4.32%)
AMD   119.47 (+1.07%)
T   15.82 (+0.51%)
F   12.11 (+0.92%)
MU   69.09 (+1.30%)
CGC   0.83 (+0.00%)
GE   104.66 (+3.08%)
DIS   88.59 (+0.72%)
AMC   4.55 (+0.89%)
PFE   38.04 (+0.03%)
PYPL   63.05 (+1.71%)
NFLX   403.13 (+2.00%)
LON:MDC

Mediclinic International (MDC) Share Forecast, Price & News

GBX 501
0.00 (0.00%)
(As of 05/26/2023)
Compare
Today's Range
501
501
50-Day Range
494.17
501
52-Week Range
366.80
514
Volume
N/A
Average Volume
2.68 million shs
Market Capitalization
£3.69 billion
P/E Ratio
2,178.26
Dividend Yield
0.60%
Price Target
GBX 484

Mediclinic International MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
3.4% Downside
GBX 484 Price Target
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

0.67 out of 5 stars


MDC stock logo

About Mediclinic International (LON:MDC) Stock

Mediclinic International plc, together with its subsidiaries, operates private hospitals. The company offers specialist-orientated and multidisciplinary healthcare services under the Mediclinic and Hirslanden brand names. It operates 74 hospitals, 20 day case clinics, 22 outpatient clinics, 5 subacute hospitals, 2 mental health facilities, and 453 theatres with approximately 11,538 inpatient beds in Switzerland, South Africa, Namibia, the Middle East, and the United Kingdom. The company also provides treasury, hospital equipment and procurement, emergency medical, management, food and catering, healthcare management, and debt collection and related services; manages healthcare staff; and owns and manages properties. In addition, it engages in the intellectual property holding and medical store/procurement businesses. The company was founded in 1983 and is based in Stellenbosch, South Africa.

Receive MDC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mediclinic International and its competitors with MarketBeat's FREE daily newsletter.

MDC Stock News Headlines

“One-Stock Millionaire” IGNORES 99.9% of the Market
During the 2008 financial crisis, millionaire trader Jeff Clark stunned the world when he managed to double his readers’ money 26 TIMES… CNBC caught wind of this and asked Jeff to come on live TV to explain his secret.
Form 8.3 - MDC LN Equity 23-February-23 Dealing Disclosure
Master Market Movements: Free Stock Analysis Report with Predictive Buy/Sell/Hold Insights!
Get a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation.
Form 8.3 - Mediclinic International plc Amendment
Earnings Preview For M.D.C. Holdings
Form 8.3 - MDC LN Equity 18-January-23 Dealing Disclosure
Form 8.3 - MDC LN Equity 25-November-22 Dealing Disclosure
Form 8.3 - Mediclinic International plc - Amendment
Mediclinic International plc (MDC.L)
Form 8.3 - Mediclinic International plc
See More Headlines

MDC Price History

Industry, Sector and Symbol

Industry
Medical Care
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
30,470
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
GBX 484
High Stock Price Forecast
GBX 504
Low Stock Price Forecast
GBX 464
Forecasted Upside/Downside
-3.4%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

Net Income
£169 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£3.38 billion
Cash Flow
GBX 62.27 per share
Book Value
GBX 481 per share

Miscellaneous

Free Float
N/A
Market Cap
£3.69 billion
Optionable
Optionable
Beta
0.42

Key Executives

  • Dr. Carel Aron van der Merwe D.A. (SA) (Age 60)
    F.C.A. (SA), M.B.Ch.B., Group CEO & Exec. Director
    Comp: $1.37M
  • Mr. Petrus Jurgens Myburgh (Age 48)
    Group CFO & Exec. Director
    Comp: $918k
  • Mr. Koert H. S. Pretorius B.Compt (Age 60)
    MBL, Group Chief Operating Officer
  • Dr. Dirk C. Le Roux (Age 63)
    Group Chief Information Officer
  • Mr. James Arnold
    Head of Investor Relations
  • Mr. Gert C. Hattingh B.Acc. (Hons) (Age 58)
    CA(SA), Group Chief Governance Officer
  • Mr. Biren Valodia
    Chief Marketing Officer of Medi-Clinic Southern Africa
  • Ms. Clara Findlay
    Chief Legal Officer of Medicalinic Southern Africa
  • Mr. Wimpie Aucamp
    Chief Operating Officer of Medi-Clinic for Southern Africa
  • Mr. David J. Hadley (Age 49)
    Chief Exec. Officer of Medicalinic Middle East













MDC Stock - Frequently Asked Questions

Should I buy or sell Mediclinic International stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Mediclinic International in the last year. There are currently 2 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" MDC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MDC, but not buy additional shares or sell existing shares.
View MDC analyst ratings
or view top-rated stocks.

What is Mediclinic International's stock price forecast for 2023?

2 analysts have issued 12 month target prices for Mediclinic International's stock. Their MDC share price forecasts range from GBX 464 to GBX 504. On average, they expect the company's share price to reach GBX 484 in the next twelve months. This suggests that the stock has a possible downside of 3.4%.
View analysts price targets for MDC
or view top-rated stocks among Wall Street analysts.

How have MDC shares performed in 2023?

Mediclinic International's stock was trading at GBX 498 at the beginning of the year. Since then, MDC shares have increased by 0.6% and is now trading at GBX 501.
View the best growth stocks for 2023 here
.

Is Mediclinic International a good dividend stock?

Mediclinic International (LON:MDC) pays an annual dividend of GBX 3 per share and currently has a dividend yield of 0.60%. The dividend payout ratio is 1,304.35%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for MDC.

What other stocks do shareholders of Mediclinic International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Mediclinic International investors own include Intu Properties (INTU), Capital & Counties Properties PLC (CAPC), Rdi Reit (RDI), British American Tobacco (BATS), Central Asia Metals (CAML), DRDGOLD (DRD), UK Oil & Gas (UKOG), Spire Healthcare Group (SPI), Premier Oil (PMO) and Ferrexpo (FXPO).

What is Mediclinic International's stock symbol?

Mediclinic International trades on the London Stock Exchange (LON) under the ticker symbol "MDC."

How do I buy shares of Mediclinic International?

Shares of MDC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Mediclinic International's stock price today?

One share of MDC stock can currently be purchased for approximately GBX 501.

How much money does Mediclinic International make?

Mediclinic International (LON:MDC) has a market capitalization of £3.69 billion and generates £3.38 billion in revenue each year. The company earns £169 million in net income (profit) each year or GBX 0.23 on an earnings per share basis.

How many employees does Mediclinic International have?

The company employs 30,470 workers across the globe.

How can I contact Mediclinic International?

Mediclinic International's mailing address is 6th Floor 65 Gresham Street, LONDON, EC2V 7NQ, United Kingdom. The official website for the company is www.mediclinic.com. The company can be reached via phone at +44-20-79549600.

This page (LON:MDC) was last updated on 6/1/2023 by MarketBeat.com Staff

My Account -